| Report ID | 242358 |
| Drug Identification Number | 02295415 |
| Brand name | TEVA-OMEPRAZOLE |
| Common or Proper name | TEVA-OMEPRAZOLE 20MG TAB |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | OMEPRAZOLE |
| Strength(s) | 20MG |
| Dosage form(s) | TABLET (DELAYED-RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | A02BC |
| ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-11-07 |
| Estimated end date | 2026-04-20 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2026-03-05 |
| Company comments | On Allocation |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v62 | 2026-03-05 | French | Compare |
| v61 | 2026-03-05 | English | Compare |
| v60 | 2026-02-26 | French | Compare |
| v59 | 2026-02-26 | English | Compare |
| v58 | 2026-02-05 | French | Compare |
| v57 | 2026-02-05 | English | Compare |
| v56 | 2025-12-18 | French | Compare |
| v55 | 2025-12-18 | English | Compare |
| v54 | 2025-12-12 | French | Compare |
| v53 | 2025-12-12 | English | Compare |
| v52 | 2025-11-20 | French | Compare |
| v51 | 2025-11-20 | English | Compare |
| v50 | 2025-11-13 | French | Compare |
| v49 | 2025-11-13 | English | Compare |
| v48 | 2025-11-06 | French | Compare |
| v47 | 2025-11-06 | English | Compare |
| v46 | 2025-10-16 | French | Compare |
| v45 | 2025-10-16 | English | Compare |
| v44 | 2025-10-10 | French | Compare |
| v43 | 2025-10-10 | English | Compare |